Correlation Between Quality of Life and Severity of Parkinson's Disease
NCT ID: NCT04110106
Last Updated: 2019-10-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
513 participants
OBSERVATIONAL
2018-02-01
2019-09-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A multicenter, cross-sectional study was performed in central and northern Italy. This study was conducted on a cohort of consecutive individuals at three neurologic outpatient clinics. All participants were evaluated with the PDQ-39, and the severity of PD was recorded according to the H\&Y scale by a neurologist. Receiver operating characteristic (ROC) curves and coordinates of the curve, which were visually inspected, were used to find cut-off points with optimal sensitivity and specificity. These were in turn used to determine the optimal PDQ-39 cut-off score for identifying disease severity according to H\&Y stages.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Quality of Life in Individuals With Parkinson's Disease
NCT05906693
Reliability and Validity of DIDA-Q in Parkinson's Disease
NCT06880068
Training of Nursing Home Professionals and Quality of Life of Residents With Parkinson's Disease
NCT06908460
Non-motor Symptoms, Balance, Muscle Strength, and Functional Mobility in Patients With Parkinson's Disease
NCT04420910
Impact of Rehabilitation in Quality of Life in PD
NCT02756676
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
no intervention
All participants were evaluated with the PDQ-39, and the severity of PD was recorded according to the H\&Y scale by a neurologist.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* H\&Y stages I, II, III, and IV,
* a mini-mental state examination \> 22 points,
* a minimum level of five years of education.
Exclusion Criteria
50 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
R.O.M.A. - Rehabilitation & Outcome Measures Assessment
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Giovanni Galeoto
Department of Public Health and Infection disease, Sapienza University of Rome
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Human Neurosciences, Sapienza University of Rome
Roma, RM, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Quality of Life and Parkinson
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.